https://doi.org/10.1016/s1470-2045(21)00493-9
A
Arthur James
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
127
Papers
1.7K
Citations
18
h-index
29
i10-index
Arthur James is an academic researcher. The author has contributed to research in topics: Trauma and Emergency Care Studies & Cardiac Arrest and Resuscitation & Intensive Care Unit Cognitive Disorders. The author has an h-index of 18, co-authored 108 publications.
ORCID: 0000-0002-1172-6398Papers by this author
worksEffect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
2021 · The Lancet Oncology · 282 citations
Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study
2022 · American Journal of Obstetrics and Gynecology · 58 citations
https://doi.org/10.1016/j.ajog.2022.06.052
Node-making process in network meta-analysis of nonpharmacological treatment are poorly reported
2017 · Journal of Clinical Epidemiology · 48 citations
https://doi.org/10.1016/j.jclinepi.2017.11.018
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score
2021 · British journal of surgery · 46 citations
https://doi.org/10.1093/bjs/znab183
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · The Lancet Diabetes & Endocrinology · 36 citations
https://doi.org/10.1016/s2213-8587(23)00253-x
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · The Lancet Diabetes & Endocrinology · 36 citations
https://doi.org/10.1016/s2213-8587(23)00253-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat